Antibody evasion properties of SARS-CoV-2 Omicron sublineages

The identification of the Omicron (B.1.1.529.1 or BA.1) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Botswana in November 2021(1) immediately caused concern owing to the number of alterations in the spike glycoprotein that could lead to antibody evasion. We(2) and other...

Descripción completa

Detalles Bibliográficos
Autores principales: Iketani, Sho, Liu, Lihong, Guo, Yicheng, Liu, Liyuan, Chan, Jasper F.-W., Huang, Yiming, Wang, Maple, Luo, Yang, Yu, Jian, Chu, Hin, Chik, Kenn K.-H., Yuen, Terrence T.-T., Yin, Michael T., Sobieszczyk, Magdalena E., Huang, Yaoxing, Yuen, Kwok-Yung, Wang, Harris H., Sheng, Zizhang, Ho, David D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021018/
https://www.ncbi.nlm.nih.gov/pubmed/35240676
http://dx.doi.org/10.1038/s41586-022-04594-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021018/
https://www.ncbi.nlm.nih.gov/pubmed/35240676
http://dx.doi.org/10.1038/s41586-022-04594-4

Ejemplares similares